January 15, 2026
Finance

Calavo Growers Shares Surge Amid Merger Announcement and Strong Fiscal Results

After-hours trading sees nearly 13% jump following deal with Mission Produce and robust year-end financials

Loading...
Loading quote...

Summary

Calavo Growers Inc. saw a substantial increase in its share price in after-hours trading following the announcement of a definitive merger agreement with Mission Produce Inc. and the release of its fiscal year 2025 earnings. The proposed acquisition values Calavo shares at $27 each, combining cash and Mission stock, positioning the merged entity for significant cost synergies. Despite a decrease in net sales, Calavo reported marked improvements in net income and adjusted earnings. The merger and financial disclosures have driven renewed investor interest, reflected in the stock’s after-hours performance.

Key Points

Calavo Growers to be acquired by Mission Produce with a $27-per-share offer combining cash and stock.
Fiscal 2025 net income from continuing operations increased 192%, despite a decline in net sales.
Anticipated $25 million in cost synergies from the merger, expected to close by August.
Q4 showed lower sales but swung to positive net income compared to previous year's loss.

Shares of Calavo Growers Inc. (NASDAQ: CVGW) experienced a notable surge in after-hours trading, climbing nearly 13% to $25.50. This increase followed the company’s latest financial disclosures and the formal announcement of a merger agreement with another California-based company, Mission Produce Inc. (NASDAQ: AVO).

Details of the Merger Agreement

Calavo Growers has entered into a definitive agreement to be acquired by Mission Produce. The deal sets the acquisition price for Calavo shares at $27 per share. This valuation is based on Mission Produce’s volume-weighted average price over 30 trading days, ending on January 13. The transaction structure includes a combination of cash and stock consideration, specifically $14.85 in cash plus 0.9790 shares of Mission for each share of Calavo.

According to official statements, shareholders of Mission Produce are expected to hold approximately 80.3% ownership in the combined entity post-merger, while Calavo shareholders will own about 19.7%. The transaction aims to realize approximately $25 million in cost synergies, enhancing operational efficiencies. Completion is anticipated by August, pending the usual regulatory approvals and shareholder consents.

Financial Performance for Fiscal Year 2025

Calavo Growers reported robust financial results for its fiscal year ending October 31, 2025. Net income from continuing operations surged to $20 million, marking a 192% increase compared to the $6.8 million recorded in fiscal 2024.

The company’s adjusted net income from continuing operations rose 42% to $28.9 million, translating to $1.62 per diluted share. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) grew 12%, reaching $40.8 million, up from $36.5 million the previous year.

Despite these improvements, total net sales declined modestly to $648.4 million, down from $661.5 million in the previous fiscal year.

Quarterly Highlights for Q4

In the fourth quarter, Calavo Growers’ net sales decreased to $124.7 million from $170 million recorded in the same quarter a year earlier. However, the company reversed a previous quarterly net loss to report a net income from continuing operations of $3.8 million, compared to a net loss of $2.5 million in the fourth quarter of fiscal 2024.

Trading Metrics and Market Position

As of recent trading, Calavo’s Relative Strength Index (RSI) is at 64.92, suggesting moderate momentum. Over the past 12 months, the company’s stock price has seen a slight increase of 0.27%, indicating a generally stable but mild upward trend over the longer term.

Calavo’s market capitalization stands at approximately $403.13 million. Within the last 52 weeks, the stock price has fluctuated between a low of $18.40 and a high of $28.72. Closing recently at $22.58, the stock had gained 1.71% during the regular trading session before the after-hours surge.

The current stock price sits near 40.54% of its 52-week trading range, situating it closer to the lower boundary than the upper one. Further metrics from equity ranking services reflect a high value score of 83.39, denoting favorable valuation characteristics relative to peers.

Outlook and Transaction Impact

The combination with Mission Produce is expected to reshape the competitive landscape for Calavo Growers. The merger promises to bring operational savings along with expanded market capabilities. However, the finalization of the deal remains contingent on a series of approvals from both regulatory bodies and shareholders.

Summary

In summary, Calavo Growers’ shares responded strongly to the merger announcement and solid fiscal results. While the company faces a decline in sales, its profitability measures have improved markedly. The pending acquisition by Mission Produce is poised to consolidate the two firms’ strengths and deliver expected cost efficiencies, creating notable shareholder value potential pending successful closure.


Key Points

  • Calavo Growers agreed to be acquired by Mission Produce at $27 per share, combining cash and stock components.
  • Fiscal year 2025 showed a 192% increase in net income from continuing operations despite a slight sales decline.
  • The merger is projected to generate $25 million in cost synergies and could close by August, subject to approvals.
  • Q4 sales declined, but profitability turned positive compared with a loss in the previous year’s quarter.

Risks and Uncertainties

  • The proposed transaction’s completion depends on regulatory clearances and shareholder approval, which introduces uncertainty around timing and successful closing.
  • Decreased overall net sales in both the full year and fourth quarter may challenge sustained profitability improvement.
  • Market volatility and trading position nearer to the lower end of its annual range could affect investor sentiment.
  • Integration risks post-merger could impact realization of the anticipated $25 million in cost synergies.
Risks
  • Transaction completion is subject to regulatory approvals and shareholder consent, creating uncertainty.
  • Net sales decreases could pressure future earnings performance.
  • The stock is trading closer to its 52-week low than high, indicating potential market caution.
  • Post-merger integration could encounter challenges affecting synergy realization.
Disclosure
Education only / not financial advice
Search Articles
Category
Finance

Financial News

Ticker Sentiment
CVGW - positive
Related Articles
Fiserv Reports Mixed Q4 2025 Results; Shares Rise on Earnings Beat

Fiserv, Inc. released its fiscal fourth-quarter 2025 financial results showing flat adjusted revenue...

AstraZeneca Posts Solid Q4 Earnings, Shares Rally Near 52-Week High

AstraZeneca Plc reported fourth-quarter 2025 revenue of $15.50 billion, slightly above expectations,...

Upstart Holdings Posts Robust Q4 Earnings Growth, Shares Rise in Extended Trading

Upstart Holdings, Inc. reported fourth-quarter 2025 financial results that exceeded analyst expectat...

Figma Shares Climb as Analysts Predict Software Sector Recovery

Figma Inc's stock experienced a notable uptick amid a broader rally in software equities. Analysts a...

SoFi Shares Slip Slightly Despite Strong Q4 Earnings and Bullish Outlook

SoFi Technologies Inc’s stock saw a minor decline Tuesday afternoon following a period of heighten...

Becton Dickinson Faces Market Headwinds Amid Transition and Revised Earnings Projections

Becton Dickinson & Co. posted first-quarter earnings above analyst expectations but trimmed its fisc...